3 Stocks Boosting The Real Estate Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 84 points (0.5%) at 17,140 as of Wednesday, Sept. 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,536 issues advancing vs. 1,417 declining with 186 unchanged.

The Real Estate industry currently sits up 0.2% versus the S&P 500, which is up 0.4%. Top gainers within the industry include Host Hotels & Resorts ( HST), up 1.6%, Brookfield Property Partners ( BPY), up 1.3%, Realogy Holdings ( RLGY), up 1.2%, Icahn ( IEP), up 0.8% and Boston Properties ( BXP), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Ventas ( VTR) is one of the companies pushing the Real Estate industry higher today. As of noon trading, Ventas is up $0.66 (1.1%) to $61.36 on average volume. Thus far, 865,243 shares of Ventas exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $60.63-$61.60 after having opened the day at $60.69 as compared to the previous trading day's close of $60.70.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. Ventas has a market cap of $18.0 billion and is part of the financial sector. Shares are up 6.0% year-to-date as of the close of trading on Tuesday. Currently there are 3 analysts who rate Ventas a buy, 3 analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Ventas as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, reasonable valuation levels, growth in earnings per share and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Ventas Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Ventas Medical REIT: Cramer's Top Takeaways

When it Drops, it's Time to Shop: Cramer's 'Mad Money' Recap (Tuesday 9/12/17)

Kindred Sells Skilled Nursing Facility Business for $700M

Don't Forget Why You Love Tech Stocks Like Amazon, Jim Cramer Explains

High-Dividend Ventas: A Dual Play on Real Estate and Health Care